Tirzepatide Dosage in Studies and on the Label
Which Tirzepatide amounts were used in studies?
The label calls for one under-the-skin shot every week; the shot doesn't belong in a vein or muscle.
The FDA label starts at 2.5 mg each week for four weeks; after that, the amount rises in steps. The slow change allows your body to adjust; it may also ease side effects. Most large studies used three long-term amounts: 5 mg, 10 mg, and 15 mg. The highest studied and approved amount is 15 mg each week.
Blood levels need about five days to fall halfway; that timing allows a weekly shot. This page reports the tirzepatide dosage in the label and studies; it can't pick the right amount for your health.
You and your doctor make that choice together.
Tirzepatide dosage: why do the amounts rise slowly?
The FDA label starts Tirzepatide at 2.5 mg each week for four weeks; the amount then rises about once a month. The steps are 5 mg, 7.5 mg, 10 mg, 12.5 mg, and no more than 15 mg each week [12]. Nausea, vomiting, and diarrhea may worsen after an increase; they often ease during weeks two through four. Slow steps can make the medicine easier to bear.
SURPASS-2 and SURMOUNT-1 followed people with type 2 diabetes or obesity; they tested 3 long-term amounts: 5, 10, and 15 mg each week. Larger amounts brought larger average drops in weight and three-month sugar readings.
At 72 weeks in the weight study, people had lost 15.0% at 5 mg. They lost 19.5% at 10 mg and 20.9% at 15 mg; the placebo group lost 3.1% [4]. In the diabetes study, the sugar reading fell 2.01, 2.24, and 2.30 percentage points [3].
An average can't choose your amount; your doctor weighs your health against side effects.
Tirzepatide dose: why does one shot cover a week?
Blood levels take about five days to fall halfway; doctors call this a drug's half-life. A fatty part fastens tirzepatide to a blood protein; your kidneys then remove it slowly. That slower removal lets one shot last through the week.
A small phase 1 study checked this timing during the first human tests; it followed 48 Japanese adults with type 2 diabetes. Their blood levels again took about five days to fall halfway [37]. A larger review of phase 3 studies, done late in testing, also supported weekly use [38].
Your body breaks tirzepatide into small parts; researchers attached a tag they could detect, then traced those parts as they left the body. About 66% left in urine, while 33% left in stool [39]; this finding tells you how broken medicine leaves the body. It doesn't set the amount you take.
Another study followed people whose livers didn't work well; their blood levels didn't change enough to require a different amount [40]. Your doctor still takes liver health into account.
Tirzepatide injection: where does the shot go?
An approved Tirzepatide injection goes under the skin; the label names the belly, thigh, or upper arm. Studies didn't put the shot into a vein or muscle.
Sold forms are kept cold, and studies used liquid under the skin; storage rules depend on the form you receive. Safe handling directions come from the FDA label [12]; your package gives you the exact storage details.
SURMOUNT-5 used the largest amount each person could bear; that meant 10 or 15 mg, rather than one fixed amount. Some people could manage 10 mg but not 15 mg [5].
Amounts differed, but every study shot went beneath the skin.
Tirzepatide peptide: what makes up the shot?
Tirzepatide peptide means the medicine is one short chain; its 39 each amino acid is a small piece also used to build protein. The chain copies one gut hormone; a few changed parts let the same chain copy GLP-1, another gut hormone. GLP-1 affects hunger and how fast the stomach empties.
What matters to you is how that chain acts in people; the shot carries a carefully made form of the chain. Human studies show its possible benefits and harms; a chemical description alone can't tell you either one.
Older medicines in this group copy one gut hormone; Tirzepatide uses one chain to copy two. That two-hormone action may help explain its larger changes in direct studies [1][2].
In short, the chain's shape lets one shot copy two gut messages.